Oral decitabine/cedazuridine versus intravenous decitabine for acute myeloid leukaemia: A randomised, crossover, registration, pharmacokinetics study.
Geissler K, Koristek Z, Del Castillo TB, Novák J, Rodríguez-Macías G, Metzelder SK, Illes A, Mayer J, Arnan M, Keating MM, Krauter J, Lunghi M, Fracchiolla NS, Platzbecker U, Santini V, Sano Y, Oganesian A, Keer H, Lübbert M.
Geissler K, et al.
Br J Haematol. 2024 Nov;205(5):1734-1745. doi: 10.1111/bjh.19741. Epub 2024 Sep 23.
Br J Haematol. 2024.
PMID: 39313917
Clinical Trial.